The CEOs of Pfizer and BioNTech seem to be backing off their own vaccine. Is it because news of the serious safety problems, in addition to the efficacy problems, is leaking out into public consciousness? Note that there is no Omicron vaccine, so Sahin is really saying that natural immunity to Omicron is likely to provide broad protection–something that was widely denied until–now.
“BioNTech CEO Uğur Şahin cast doubt on the need for COVID-19 vaccines that would defend against multiple variants. It’s one “opportunity,” he said Tuesday, but “at the moment we have a situation where we do not know what is the next variant.”
Plus, Şahin said, “omicron infection and an omicron vaccine would most likely boost immune responses against all existing variants.“
In 2021, the COVID-19 vaccine BioNTech developed with partner Pfizer accounted for 74% of the market share in the U.S. and 80% in Europe, the company estimates.”